Volume 37, Issue 3 pp. E34-E37
Case Report (ONLINE ONLY)

Single-fraction stereotactic body radiation therapy for sinonasal malignant melanoma

Daniel J. Bourgeois III MD, MPH

Daniel J. Bourgeois III MD, MPH

University at Buffalo School of Medicine, Roswell Park Cancer Institute, Buffalo, New York

Search for more papers by this author
Anurag K. Singh MD

Corresponding Author

Anurag K. Singh MD

University at Buffalo School of Medicine, Roswell Park Cancer Institute, Buffalo, New York

Corresponding author: A. K. Singh, University at Buffalo School of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo NY 14263. E-mail: [email protected]Search for more papers by this author
First published: 31 May 2014
Citations: 9

Abstract

Background

A rare head and neck disease that may benefit from definitive or palliative stereotactic body radiation therapy (SBRT) is sinonasal malignant melanoma. These tumors can be very aggressive and often lead to severe epistaxis and significant mass effect. Results from only a handful of head and neck sinonasal malignant melanoma treated with SBRT are available in the current literature.

Methods

The following reports on 2 cases of sinonasal malignant melanoma that recurred postoperatively and were subsequently treated at Roswell Park with SBRT. Both were treated with a single fraction of 15 Gy.

Results

Nearly instant relief of their chronic epistaxis and complete responses were seen in both patients. One patient is alive and free of disease 7 years after radiation.

Conclusion

These patients with sinonasal malignant melanoma achieved symptomatic relief of severe bleeding and airway issues from single-fraction SBRT. SBRT should be considered as a treatment option in patients with unresectable sinonasal malignant melanoma. © 2014 Wiley Periodicals, Inc. Head Neck 37: E34–E37, 2015

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.